v3.26.1
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes the activities for all stock options under the Company’s stock-based compensation plans for the nine months ended September 30, 2025:
Number of Options OutstandingWeighted-Average Exercise PriceWeighted-Average Remaining Contractual TermAggregate Intrinsic Value(1)
Outstanding as of December 31, 2024(2)8,438 $12.93 3.16 years$152 
Granted— $— 
Exercised(27)$2.64 
Forfeited or expired(3)(363)$11.41 
Outstanding as of September 30, 2025(2)8,048 $13.03 3.46 years$516 
Exercisable as of September 30, 2025(4)7,989 $13.07 3.43 years$497 
Vested and expected to vest as of September 30, 2025(5)8,048 $13.03 3.46 years$516 
(1)The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards.
(2)Includes 3,539 and 3,620 performance condition stock options as of September 30, 2025 and December 31, 2024, respectively.
(3)Includes 81 performance condition stock options.
(4)Includes 3,539 performance condition stock options.
(5)Includes 3,539 performance condition stock options.
Schedule of Restricted Stock Unit Activity
The following table summarizes the activities for all RSUs under the Company’s stock-based compensation plans for the nine months ended September 30, 2025:
Number of SharesWeighted-Average Grant Date Fair Value Per Share
Outstanding as of December 31, 2024(1)1,902 $4.94 
Granted(2)1,753 $3.25 
Vested(563)$5.79 
Forfeited(3)(559)$5.01 
Outstanding as of September 30, 2025(1)2,533 $3.57 
(1)Includes 323 and 248 performance condition RSUs as of September 30, 2025 and December 31, 2024, respectively.
(2)Includes 323 performance condition RSUs.
(3)Includes 248 performance condition RSUs.
Schedule of Stock-Based Compensation Expense
The following table provides information about stock-based compensation expense by award type:
Three Months EndedNine Months Ended
September 30,
2025
September 30,
2024
September 30,
2025
September 30,
2024
Stock options$208 $422 $797 $1,455 
Restricted stock units1,046 1,405 3,133 3,608 
Employee stock purchase plan389 271 1,166 628 
Total stock-based compensation expense$1,643 $2,098 $5,096 $5,691 
The following table provides information about stock-based compensation expense by financial statement line item:
Three Months EndedNine Months Ended
September 30,
2025
September 30,
2024
September 30,
2025
September 30,
2024
Cost of revenue (exclusive of depreciation and amortization)$— $— $— $(1)
Sales and marketing280 254 798 699 
Research and development311 438 905 1,066 
General and administrative1,052 1,406 3,393 3,927 
Total stock-based compensation expense$1,643 $2,098 $5,096 $5,691